Science Explorer Back to mapMap

Most cited papers from Global Vaccines (United States)

What are the most cited papers from Global Vaccines (United States)?

The most cited paper from Global Vaccines (United States) is "Estimated global incidence of Japanese encephalitis:" (Grant L. Campbell, Susan L. Hills, Marc Fischer et al., 2011), with 1,013 citations. Next come "Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine" (362) and "A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines" (341).

Showing 50 of 59 papers. Every paper with more than 51 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Estimated global incidence of Japanese encephalitis: Grant L. Campbell, Susan L. Hills, Marc Fischer et al. · Bulletin of the World Health Organization Open access Oct 2011 1,013
2 Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine Michael J. Roy, Mary S. Wu, Lori J. Barr et al. · Vaccine Nov 2000 362
3 A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines Luis A. Brito et al. · Molecular Therapy Open access 16 Jul 2014 341
4 Effective Induction of Simian Immunodeficiency Virus-Specific Cytotoxic T Lymphocytes in Macaques by Using a Multiepitope Gene and DNA Prime-Modified Vaccinia Virus Ankara Boost Vaccination Regimen Tomáš Hanke, Rachel V. Samuel, Tom J. Blanchard et al. · Journal of Virology Open access Sep 1999 306
5 Vaccines against invasiveSalmonelladisease Calman Alexander MacLennan, Laura B. Martin, Francesca Micoli · Human Vaccines & Immunotherapeutics Open access 7 May 2014 208
6 Immunization of Rhesus Macaques with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen Induces Broad Simian Immunodeficiency Virus (SIV)-Specific T-Cell Responses and Reduces Initial Viral Replication but Does Not Prevent Disease Progression following Challenge with Pathogenic SIVmac239 Helen Horton, Thorsten U. Vogel, Donald K. Carter et al. · Journal of Virology Open access 15 Jul 2002 194
7 Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines Daniela Amicizia, Alexander Domnich, Donatella Panatto et al. · Human Vaccines & Immunotherapeutics Open access 19 Feb 2013 194
8 DNA Vaccines Expressing either the GP or NP Genes of Ebola Virus Protect Mice from Lethal Challenge Lorna Vanderzanden, Mike Bray, DEBORAH HEYDENBURG FULLER et al. · Virology Open access Jun 1998 172
9 Towards the next generation of biomedicines by site-selective conjugation Qiying Hu, Francesco Berti, Roberto Adamo · Chemical Society Reviews ReviewOpen access 2016 168
10 New generation adjuvants – From empiricism to rational design Derek T. O’Hagan, Christopher B. Fox · Vaccine 26 May 2015 165
11 Adjusting for Case Under-Ascertainment in Estimating RSV Hospitalisation Burden of Older Adults in High-Income Countries: a Systematic Review and Modelling Study You Li, Durga Kulkarni, Elizabeth M. Begier et al. · Infectious Diseases and Therapy ReviewOpen access 20 Mar 2023 162
12 Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination Scott T. Rottinghaus, Gregory A. Poland, Robert M. Jacobson et al. · Vaccine 30 Jun 2003 147
13 The vaccine adjuvant alum inhibits IL ‐12 by promoting PI 3 kinase signaling while chitosan does not inhibit IL ‐12 and enhances T h1 and T h17 responses Andrés Mori, Ewa Oleszycka, Fiona A. Sharp et al. · European Journal of Immunology 10 Jul 2012 142
14 DNA Immunization with Minigenes: Low Frequency of Memory Cytotoxic T Lymphocytes and Inefficient Antiviral Protection Are Rectified by Ubiquitination Fernando A. Rodriguez, Ling An, Stephanie S. Harkins et al. · Journal of Virology Open access Jun 1998 142
15 Combination Vaccines DavidAG Skibinski, BarbaraC Baudner, Manmohan Singh et al. · Journal of Global Infectious Diseases Open access 2011 128
16 Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: Potential implications for pneumococcal conjugate vaccines Gail L. Rodgers, Adriano G Arguedas, Robert W. Cohen et al. · Vaccine 26 Apr 2009 125
17 Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella Francesca Micoli, Simona Rondini, Renzo Alfini et al. · Proceedings of the National Academy of Sciences Open access 27 Sep 2018 123
18 Induction of Mucosal Protection against Primary, Heterologous Simian Immunodeficiency Virus by a DNA Vaccine DEBORAH HEYDENBURG FULLER, Premeela A. Rajakumar, Lawrence Wilson et al. · Journal of Virology Open access Apr 2002 114
19 Global vaccine action plan lessons learned I: Recommendations for the next decade Noni MacDonald, Ezzeddine Mohsni, Yagob Y. Al-Mazrou et al. · Vaccine Open access 4 May 2020 110
20 The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease Sandra J. Bliss, Katherine L. O'Flynn O'Brien, Edward N. Janoff et al. · The Lancet Infectious Diseases 4 Dec 2007 110
21 Dissolvable Microneedle Patches for the Delivery of Cell-Culture-Derived Influenza Vaccine Antigens Sushma Kommareddy, Barbara C. Baudner, Seajin Oh et al. · Journal of Pharmaceutical Sciences 20 Dec 2011 107
22 Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial Suzanne Marie Garland et al. · International Journal of Cancer Open access 19 Aug 2016 105
23 Modulation of Endotoxicity of Shigella Generalized Modules for Membrane Antigens (GMMA) by Genetic Lipid A Modifications Omar Rossi, Isabella Pesce, Carlo Giannelli et al. · Journal of Biological Chemistry Open access 15 Jul 2014 105
24 Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime T Hanke, Veronica C. Neumann, Tom J. Blanchard et al. · Vaccine Feb 1999 105
25 Multispecific Vaccine-Induced Mucosal Cytotoxic TLymphocytes Reduce Acute-Phase Viral Replication but Fail inLong-Term Control of Simian Immunodeficiency VirusSIVmac239 Thorsten U. Vogel, Matthew R. Reynolds, DEBORAH HEYDENBURG FULLER et al. · Journal of Virology Open access 25 Nov 2003 102
26 Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate Raphaël M. Zellweger, Robyn Miller, William E. Eddy et al. · PLoS Pathogens Open access 31 Oct 2013 102
27 Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection Alvaro Baeza Garcia, Edwin Siu, Tiffany Sun et al. · Nature Communications Open access 9 Jul 2018 100
28 Stabilization of Alum-Adjuvanted Vaccine Dry Powder Formulations: Mechanism and Application Yuh‐Fun Maa, Lu Jie Zhao, Lendon G. Payne et al. · Journal of Pharmaceutical Sciences 17 Jan 2003 100
29 A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice Viswanathan Ramasamy, Upasana Arora, Rahul Shukla et al. · PLoS neglected tropical diseases Open access 8 Jan 2018 97
30 Plasmid Vectors Encoding Cholera Toxin or the Heat-Labile Enterotoxin fromEscherichia coliAre Strong Adjuvants for DNA Vaccines Joshua Arrington, Ralph Peter Braun, Lichun Dong et al. · Journal of Virology Open access May 2002 88
31 MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020) Barbara C. Baudner, Vanessa Ronconi, Daniele Casini et al. · Pharmaceutical Research 2 Mar 2009 87
32 Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence Darron R. Brown, Elmar Armin Joura, Glorian Yen et al. · Vaccine Review 19 Mar 2021 84
33 Varicella-Zoster Virus Infection Induces Autophagy in both Cultured Cells and Human Skin Vesicles M Takahashi, Wallen Jackson, Donna T. Laird et al. · Journal of Virology Open access 19 Mar 2009 81
34 IL-15 transpresentation promotes both human T-cell reconstitution and T-cell–dependent antibody responses in vivo Nicholas D. Huntington, Nuno L. Alves, Nicolas Legrand et al. · Proceedings of the National Academy of Sciences Open access 28 Mar 2011 81
35 Preexisting subtype immunodominance shapes memory B cell recall response to influenza vaccination Rodrigo B. Abreu, Greg A. Kirchenbaum, Emily F. Clutter et al. · JCI Insight Open access 3 Dec 2019 78
36 An Alphavirus Vector-Based Tetravalent Dengue Vaccine Induces a Rapid and Protective Immune Response in Macaques That Differs Qualitatively from Immunity Induced by Live Virus Infection Laura White, Carlos A. Sariol, Melissa D. Mattocks et al. · Journal of Virology Open access 10 Jan 2013 75
37 Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial Wendy A. Keitel, Nicola Groth, Maria Lattanzi et al. · Vaccine 15 Oct 2009 73
38 Epidermal Powder Immunization Induces both Cytotoxic T-Lymphocyte and Antibody Responses to Protein Antigens of Influenza and Hepatitis B Viruses Dexiang Chen, Kathleen F. Weis, Qili Chu et al. · Journal of Virology Open access Dec 2001 72
39 The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology Vanessa Racloz, Silva JD Luiz · BMC Infectious Diseases ReviewOpen access 17 Jun 2010 70
40 Powder and particle-mediated approaches for delivery of DNA and protein vaccines into the epidermis Hansi J. Dean, DEBORAH HEYDENBURG FULLER, Jorge E. Osorio · Comparative Immunology Microbiology and Infectious Diseases 23 Apr 2003 68
41 Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization Dexiang Chen, S. Bhargava Periwal, Katherine Larrivee et al. · Journal of Virology Open access Sep 2001 68
42 Development of Pandemic Vaccines: ERVEBO Case Study Jayanthi J. Wolf, Risat Jannat, Sheri A. Dubey et al. · Vaccines Open access 25 Feb 2021 67
43 A systematic literature review to assess the burden of herpes zoster disease in China Dapeng Yin, Desirée Van Oorschot, Ning Jiang et al. · Expert Review of Anti-infective Therapy ReviewOpen access 30 Sep 2020 66
44 Coadministration of DNA Encoding Interleukin-6 and Hemagglutinin Confers Protection from Influenza Virus Challenge in Mice Diane L. Larsen, Naomi Dybdahl-Sissoko, Martha W. McGregor et al. · Journal of Virology Open access Feb 1998 66
45 Comparison of Immunity Generated by Nucleic Acid-, MF59-, and ISCOM-Formulated Human Immunodeficiency Virus Type 1 Vaccines in Rhesus Macaques: Evidence for Viral Clearance Ernst J. Verschoor, Petra Mooij, Herman Oostermeijer et al. · Journal of Virology Open access Apr 1999 65
46 Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data Stefania Vergnano et al. · Vaccine Open access 3 Aug 2016 62
47 Development of a glycoconjugate vaccine to prevent meningitis in Africa caused by meningococcal serogroup X Francesca Micoli, Maria Rosaria Romano, Marta Tontini et al. · Proceedings of the National Academy of Sciences Open access 4 Nov 2013 62
48 Regional antibody and cellular immune responses to equine influenza virus infection, and particle mediated DNA vaccination G Soboll, D.W. Horohov, Brian M Aldridge et al. · Veterinary Immunology and Immunopathology 3 Jun 2003 62
49 Adjuvantation of epidermal powder immunization Dexiang Chen, Cherie A. Erickson, Ryan L. Endres et al. · Vaccine Apr 2001 61
50 The impact of the COVID-19 pandemic on vaccination uptake in the United States and strategies to recover and improve vaccination rates: A review Luke Cunniff, Elif Alyanak, Alessandra Fix et al. · Human Vaccines & Immunotherapeutics Open access Aug 2023 60

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.